Zobrazeno 1 - 10
of 254
pro vyhledávání: '"Kyu-pyo Kim"'
Autor:
Myoung Joo Kang, Ghassan K. Abou-Alfa, Jaekyung Cheon, Kyu-Pyo Kim, Baek-Yeol Ryoo, Il Hwan Kim, Kyung Won Kim, Byung Woog Kang, Jae Ho Jeong, Ji Sung Lee, Hyewon Ryu, Changhoon Yoo
Publikováno v:
The Lancet Oncology. 22:1560-1572
Summary Background The prognosis of patients with advanced biliary tract cancer who have progressed on gemcitabine plus cisplatin is dismal. We aimed to investigate the efficacy and safety of second-line liposomal irinotecan plus fluorouracil and leu
Autor:
Eo Jin Kim, Kang Mo Kim, Han Chu Lee, Kyu-Pyo Kim, Young-Suk Lim, Jonggi Choi, Hyo Jeong Kang, Baek-Yeol Ryoo, Ju Hyun Shim, Changhoon Yoo, Min-Hee Ryu, Sook Ryun Park, Danbi Lee
Publikováno v:
Liver International. 41:1398-1408
BACKGROUND & AIMS The optimal systemic chemotherapy for combined hepatocellular-cholangiocarcinoma (cHCC-CCA) has not yet been defined. The definition and classification of cHCC-CCA has changed recently in the 5th edition of WHO classification. We re
Autor:
Kyu-Pyo Kim, Ji Sung Lee, Tae Won Kim, Jeong Eun Kim, Yong Sang Hong, Sun Young Kim, Yeong Hak Bang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
There is an unmet medical need for later-line treatment options for patients with metastatic colorectal cancer (mCRC). Considering that, beyond progression, co-treatment with bevacizumab and cytotoxic chemotherapy showed less toxicity and a significa
Autor:
김규표 ( Kyu-pyo Kim )
Publikováno v:
The Korean Journal of Medicine. 95:382-386
Precision medicine is the modern era version of “personalized medicine”, which integrates data from genomics and clinical information to optimize the care delivered to patients. As next generation sequencing (NGS) revolutionized the speed and cos
Autor:
Jaewoo Kwon, Heung-Moon Chang, Tae Jun Song, Dong Wan Seo, Kyu-Pyo Kim, Sang Soo Lee, Dongwook Oh, Jae Hoon Lee, Jae Ho Jeong, Sung Koo Lee, Changhoon Yoo, Ki Byung Song, J.H. Kim, Baek-Yeol Ryoo, Woohyung Lee, Dae Wook Hwang, Myung-Hwan Kim, Yejong Park, Song Cheol Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study evaluated the efficacy of adjuvant chemotherapy (AC) in patients with resected ampulla of Vater (AoV) carcinoma.Materials and Methods Data from 646 patients who underwent surgical resection at Asan Medical Center between 2000 and 2
Autor:
Haeng-Jin Lee, Ho Yong Park, Eun Kyu Kim, S. J. Nam, Kyu-Pyo Kim, HG Moon, Sinwon Lee, Byung-Ho Son, Yun-Shik Choi, YW Ju, Wonshik Han, Sung Ho Ahn, Hwan Ki Kim, Wookyung Park, Jaewang Lee, D-Y Noh
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020)
Scientific Reports
Scientific Reports
We investigated the relationship between the prognostic importance of anatomic tumour burden and subtypes of breast cancer using data from the Korean Breast Cancer Registry Database. In HR+/HER2+ and HR−/HER2−tumours, an increase in T stage profo
Autor:
Song Cheol Kim, Changhoon Yoo, Kyu-Pyo Kim, Hyoung Jung Kim, Jae Ho Byun, Ji Hun Kang, Jong Keon Jang, Dong Wan Seo, Moon-Gyu Lee, Seung Soo Lee, Jung Hee Son, Seung-Mo Hong, Jin Hee Kim
Publikováno v:
European Radiology. 31:813-823
We aimed to assess the ability of CT-determined resectability, as defined by a recent version of NCCN criteria, and associated CT findings to predict margin-negative (R0) resection in patients with PDAC after neoadjuvant FOLFIRINOX chemotherapy. Sixt
Autor:
Hyung-seung Jin, Eun Kyung Choi, Yoon Park, Seong-Ho Kang, Inki Kim, Kyu-Pyo Kim, Da-som Choi, Hee Jin Lee, Minkyung Ko, June Hyuck Kim, Changhoon Yoo, Dong Hee Lee
Publikováno v:
Cancer Immunology Research. 8:912-925
Clinical trials are evaluating the efficacy of anti-TIGIT for use as single-agent therapy or in combination with programmed death 1 (PD-1)/programmed death-ligand 1 blockade. How and whether a TIGIT blockade will synergize with immunotherapies is not
Autor:
Shin Hwang, Hee-Sang Hwang, Seung-Mo Hong, Dae Wook Hwang, Do Hyun Park, Ki-Hun Kim, Baek-Yeol Ryoo, Kyu-Pyo Kim, Jae Ho Jeong, Tae Jun Song, Changhoon Yoo, Dongwook Oh, Junho Kang, Sang Soo Lee, Song Cheol Kim, Jin-Hong Park
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The current standard chemotherapy for advanced biliary tract cancer (BTC) has limited benefit, and novel therapies need to be investigated. Materials and MethodsIn this prospective cohort study, programmed death ligand-1 (PD-L1)–positive BT
Autor:
Sun Young Kim, Chang Sik Yu, Jong Hoon Kim, Ji Sung Lee, Tae-You Kim, Jeong Eun Kim, Ji Yeon Baek, Joon Oh Park, Seong Hyeon Yun, Kyung Hae Jung, Joong Bae Ahn, Keun Wook Lee, Byung-Ho Nam, Kyu Pyo Kim, Young Suk Park, Seok Byung Lim, Hee Chul Park, Jin-Hong Park, Yong Sang Hong, Jin Cheon Kim, Tae Won Kim
Publikováno v:
Journal of Clinical Oncology. 37:3111-3123
PURPOSE We evaluated the role of oxaliplatin as adjuvant chemotherapy in patients with rectal cancer who received preoperative chemoradiotherapy (CRT) with fluoropyrimidine monotherapy and total mesorectal excision (TME). METHODS The ADORE trial (adj